Official Statement Tuesday, September 9, 2025 – The crisis affecting raw materials, whose production has been blocked for a year now, is becoming increasingly serious. F.I.G. has entered into a partnership with Driada Medical to maintain the highest possible quality, quantity, and competitive pricing of its products.
Dear customers,
Big changes at F.I.G.! Starting in the coming days, our brand will be associated with that of Driada Medical, in a transition phase that, from the beginning of 2026, will see our entire range completely absorbed and replaced by that of Driada, one of the most important pharmaceutical companies in the sector.
This decision stems from the ongoing difficulty in sourcing the raw materials needed to manufacture our products—a problem that affects the entire supply chain and which, despite the many efforts we have made over the past year, we could not ignore.
To ensure continuity, product quality, and competitive pricing, we have decided to launch this partnership with Driada Medical. The first phase of the process will last approximately three months, during which Driada products will be gradually introduced into our catalog. Starting in early 2026, Driada Medical will take full responsibility for production, shipping, and customer service: from that date forward, the only products available will be those under the Driada brand.
Advantages of this choice:
- Quality guaranteed by a top-level company: WE will continue to test the products;
- More competitive prices compared to the Driada website;
- Much broader and more comprehensive catalog
- All the best peptides and SARMs will be added to the catalog
- Greater security in supplies, given that Driada, being a very robust company, will have fewer problems sourcing raw materials.
However, we also want to be transparent about aspects that could affect the shopping experience:
- Our support chat will no longer be active, except for the email service for order management: however, the Driada chat will always be available;
- Shipments will take a few days longer, as they are handled directly by Driada: however, there will soon be no alternative on the market;
- Cash on delivery payments will no longer be accepted because shipments will be handled entirely by Driada.
We would like to emphasize that, due to the blockage in the production of raw materials, this is currently the only possible solution and that, thanks to this collaboration, we will be able to continue to offer you quality products that meet your needs.
WARNING: Many products for this specific issue will soon be out of stock and are unlikely to be restocked before the final transition to Driada. Products such as Masteron and Primobolan (and to some extent Trenbolone) are UNLIKELY to be produced again, and the ones we have in our catalog are truly the last remaining stock: even Driada has already sold out of these products. BE WARY of the products being sold to you and found elsewhere: the market is changing, and so are the types of products!
We thank you for your trust and understanding, and remain at your disposal for any clarifications. We confirm our commitment to ensuring continuity of service.
Best regards,
Italian Pharmacy Genoa (F.I.G.)
